Carlos G. Hirth

Fortaleza, CE, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Study of phosphorylated ribosomal protein S6 (pS6) in the clinical outcomes of patients undergoing hepatectomy for metastatic colorectal cancer.

Study of phosphorylated ribosomal protein S6 (pS6) in the clinical outcomes of patients undergoing hepatectomy for metastatic colorectal cancer.

Journal: World journal of surgical oncology

Published: May 03, 2026

Study of phosphorylated ribosomal protein S6 (pS6) in the clinical outcomes of patients undergoing hepatectomy for metastatic colorectal cancer.

Study of phosphorylated ribosomal protein S6 (pS6) in the clinical outcomes of patients undergoing hepatectomy for metastatic colorectal cancer.

Journal: World journal of surgical oncology

Published: May 03, 2026

Carney complex with PRKAR1A variant and breast/fibrolamellar carcinomas.

Carney complex with PRKAR1A variant and breast/fibrolamellar carcinomas.

Journal: Human genome variation

Published: December 19, 2025

The p16 Immunostaining Predicts the Risk of Recurrence in Prostate Cancer.

The p16 Immunostaining Predicts the Risk of Recurrence in Prostate Cancer.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: March 23, 2024

The relevance of ERG immunoexpression intensity for prostatic adenocarcinoma in radical prostatectomy of 635 samples.

The relevance of ERG immunoexpression intensity for prostatic adenocarcinoma in radical prostatectomy of 635 samples.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: January 08, 2023

HPV infection and 5mC/5hmC epigenetic markers in penile squamous cell carcinoma: new insights into prognostics.

HPV infection and 5mC/5hmC epigenetic markers in penile squamous cell carcinoma: new insights into prognostics.

Journal: Clinical epigenetics

Published: June 23, 2022

Immunoexpression of HSPA9 and CUL2 in prostatic tissue and adenocarcinoma.

Immunoexpression of HSPA9 and CUL2 in prostatic tissue and adenocarcinoma.

Journal: Annals of diagnostic pathology

Published: June 18, 2021

Circulating let-7e-5p, miR-106a-5p, miR-28-3p, and miR-542-5p as a Promising microRNA Signature for the Detection of Colorectal Cancer.

Circulating let-7e-5p, miR-106a-5p, miR-28-3p, and miR-542-5p as a Promising microRNA Signature for the Detection of Colorectal Cancer.

Journal: Cancers

Published: February 09, 2021

Prognostic value of FUS immunoexpression for Gleason patterns and prostatic adenocarcinoma progression.

Prognostic value of FUS immunoexpression for Gleason patterns and prostatic adenocarcinoma progression.

Journal: Annals of diagnostic pathology

Published: July 11, 2020

EZH2 expression is dependent on MYC and TP53 regulation in diffuse large B-cell lymphoma.

EZH2 expression is dependent on MYC and TP53 regulation in diffuse large B-cell lymphoma.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: October 29, 2019

Evaluation of the diagnostic potential of CD1a immunohistochemistry for visceral leishmaniasis.

Evaluation of the diagnostic potential of CD1a immunohistochemistry for visceral leishmaniasis.

Journal: Revista do Instituto de Medicina Tropical de Sao Paulo

Published: November 28, 2018

The association among HER2, MET and FOXP3 expression and tumor regression grading in gastric adenocarcinoma.

The association among HER2, MET and FOXP3 expression and tumor regression grading in gastric adenocarcinoma.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: January 15, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026